Year To Quarter End Consolidated Statement Of Comprehensive Income

Modalis Therapeutics Corporation - Filing #7312187

Concept 2024-01-01 to
2024-06-30
2023-01-01 to
2023-06-30
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-780,946,000 JPY
-1,033,228,000 JPY
Other comprehensive income
Foreign currency translation adjustment
8,801,000 JPY
-1,676,000 JPY
Other comprehensive income
8,801,000 JPY
-1,676,000 JPY
Comprehensive income
-772,145,000 JPY
-1,034,904,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-772,145,000 JPY
-1,034,904,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.